Just a short and sweet message: we have started measuring the blood levels of naltrexone in patient’s receiving our new 1.4 gram implant. Although it is early in our study, the results are promising. At 8 weeks post-implant, the levels of opiate-blocking naltrexone are still stro ng. We are hoping this pellet will give coverage for longer than the previous 6-8 week implant.
Until we know for sure, please continue to keep your scheduled implant appointments. Remember, after 2 months of abstinence a person is a heightened risk for overdose.
It’s been a wonderful month of seeing our returning patients doing so well, reclaiming their lives without opiates.
Thursday, November 5, 2009
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment